CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Bonus BioGroup Ltd. - BBIXF CFD

    -
    0%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread -
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* N/A
    Open* N/A
    1-Year Change* N/A
    Day's Range* N/A
    52 wk Range 0.21-1.44
    Average Volume (10 days) 2.51M
    Average Volume (3 months) 105.72M
    Market Cap 249.94M
    P/E Ratio -100.00K
    Shares Outstanding 1.17B
    Revenue N/A
    EPS -0.03
    Dividend (Yield %) N/A
    Beta 2.10
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low

    Bonus BioGroup Ltd. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 0 0 0 0 0
    Revenue 0 0
    Total Operating Expense 64.735 19.444 20.909 18.45 20.13
    Selling/General/Admin. Expenses, Total 43.75 8.023 9.752 7.567 9.201
    Research & Development 19.509 10.354 10.08 10.686 10.767
    Other Operating Expenses, Total
    Operating Income -64.735 -19.444 -20.909 -18.45 -20.13
    Other, Net -24.936 -1.408 -0.195 -0.364 -0.067
    Net Income Before Taxes -90.076 -22.021 -22.24 -18.735 -20.197
    Net Income After Taxes -90.076 -22.021 -22.24 -18.735 -20.197
    Net Income Before Extra. Items -90.076 -22.021 -22.24 -18.735 -20.197
    Net Income -90.076 -22.021 -22.24 -18.735 -20.197
    Income Available to Common Excl. Extra. Items -90.076 -22.021 -22.24 -18.735 -20.197
    Income Available to Common Incl. Extra. Items -90.076 -22.021 -22.24 -18.735 -20.197
    Diluted Net Income -90.076 -22.021 -22.24 -18.735 -20.197
    Diluted Weighted Average Shares 1154.06 998.981 841.467 811.497 808.995
    Diluted EPS Excluding Extraordinary Items -0.07805 -0.02204 -0.02643 -0.02309 -0.02497
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.07805 -0.02204 -0.02643 -0.02309 -0.02497
    Depreciation / Amortization 1.476 1.067 1.077 0.197 0.162
    Interest Income (Expense), Net Non-Operating -0.405 -1.169 -1.136 0.079
    Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
    Total revenue 0 0 0 0 0
    Total Operating Expense 8.269 9.259 9.579 9.571 10.375
    Selling/General/Admin. Expenses, Total 3.679 3.745 3.645 4.117 3.635
    Research & Development 4.59 5.514 5.934 5.454 6.74
    Operating Income -8.269 -9.259 -9.579 -9.571 -10.375
    Interest Income (Expense), Net Non-Operating 0.345 4.647 2.506 -0.463 -0.005
    Other, Net -8.176 -0.681 -0.231 -5.973 -1.148
    Net Income Before Taxes -16.1 -5.293 -7.304 -16.007 -11.528
    Net Income After Taxes -16.1 -5.293 -7.304 -16.007 -11.528
    Net Income Before Extra. Items -16.1 -5.293 -7.304 -16.007 -11.528
    Net Income -16.1 -5.293 -7.304 -16.007 -11.528
    Income Available to Common Excl. Extra. Items -16.1 -5.293 -7.304 -16.007 -11.528
    Income Available to Common Incl. Extra. Items -16.1 -5.293 -7.304 -16.007 -11.528
    Diluted Net Income -16.1 -5.293 -7.304 -16.007 -11.528
    Diluted Weighted Average Shares 1167.93 1167.93 1167.93 1155.96 1153.42
    Diluted EPS Excluding Extraordinary Items -0.01379 -0.00453 -0.00625 -0.01385 -0.00999
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.01379 -0.00453 -0.00625 -0.01385 -0.00999
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 81.001 16.737 0.308 9.088 4.651
    Cash and Short Term Investments 79.55 16.086 0.105 8.641 2.725
    Cash & Equivalents 79.55 16.086 0.105 8.641 2.725
    Total Receivables, Net 1.155 0.41 0.102 0.424 1.88
    Accounts Receivable - Trade, Net
    Other Current Assets, Total
    Total Assets 104.322 51.437 6.99 10.158 5.577
    Property/Plant/Equipment, Total - Net 14.961 5.726 6.585 0.973 0.824
    Intangibles, Net 0.005
    Other Long Term Assets, Total 0.464 0.097 0.097 0.097 0.097
    Total Current Liabilities 8.771 16.374 15.545 12.45 11.961
    Accounts Payable 3.994 1.559 1.48 1.221 1.047
    Payable/Accrued
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 1.118 11.185 9.362 8.275 7.273
    Total Liabilities 19.892 20.753 20.711 13.335 11.961
    Total Long Term Debt 11.121 4.379 5.166 0 0
    Total Equity 84.43 30.684 -13.721 -3.177 -6.384
    Common Stock 296.524 156.654 85.011 68.757 65.133
    Retained Earnings (Accumulated Deficit) -212.094 -125.97 -105.346 -87.731 -71.517
    Other Equity, Total 0 6.614 15.797 0
    Total Liabilities & Shareholders’ Equity 104.322 51.437 6.99 10.158 5.577
    Total Common Shares Outstanding 1154.06 998.981 841.467 811.497 808.995
    Prepaid Expenses 0.296 0.241 0.101 0.023 0.046
    Property/Plant/Equipment, Total - Gross 20.455 9.762 9.575 2.886 2.538
    Accumulated Depreciation, Total -5.494 -4.036 -2.99 -1.913 -1.714
    Accrued Expenses 2.43 2.855 3.993 2.954 3.641
    Other Liabilities, Total 0.885
    Long Term Investments 7.896 28.877 0
    Current Port. of LT Debt/Capital Leases 1.229 0.775 0.71
    Capital Lease Obligations 11.121 4.379 5.166
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 78.283 81.001 92.565 82.69 92.77
    Cash and Short Term Investments 71.95 79.55 91.467 81.257 88.778
    Cash & Equivalents 71.95 79.55 91.467 81.257 88.778
    Total Receivables, Net 6.333 1.451 1.098 1.433 3.992
    Accounts Receivable - Trade, Net 6.333 1.451 1.098 1.433 3.992
    Total Assets 105.758 104.322 117.112 96.567 118.308
    Property/Plant/Equipment, Total - Net 18.518 14.961 12.649 1.752 5.87
    Long Term Investments 8.493 7.896 11.434 11.661 19.571
    Other Long Term Assets, Total 0.464 0.464 0.464 0.464 0.097
    Total Current Liabilities 7.859 8.771 8.409 5.385 13.358
    Accounts Payable 3.721 3.994 3.124 1.916 2.211
    Payable/Accrued 2.869 2.494 2.972 2.119 5.231
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 1.243 1.229 1.477 0.31 0.798
    Other Current Liabilities, Total 0.026 1.054 0.836 1.04 5.118
    Total Liabilities 18.742 19.892 19.7 5.385 17.518
    Total Long Term Debt 10.883 11.121 11.291 0 4.16
    Capital Lease Obligations 10.883 11.121 11.291 0 4.16
    Total Equity 87.016 84.43 97.412 91.182 100.79
    Common Stock 307.606 296.524 295.909 241.537 204.652
    Retained Earnings (Accumulated Deficit) -220.59 -212.094 -198.497 -163.729 -148.104
    Other Equity, Total 0 0 13.374 44.242
    Total Liabilities & Shareholders’ Equity 105.758 104.322 117.112 96.567 118.308
    Total Common Shares Outstanding 1167.93 1154.06 1153.42 1069.13 1067.15
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -90.076 -22.021 -22.24 -18.735 -20.197
    Cash From Operating Activities -39.839 -15.746 -13.113 -13.427 -11.823
    Cash From Operating Activities 1.476 1.067 1.077 0.197 0.163
    Non-Cash Items 57.174 4.89 5.673 3.143 7.76
    Changes in Working Capital -8.413 0.318 2.377 1.968 0.451
    Cash From Investing Activities -6.176 -0.254 -0.187 -0.341 -0.269
    Capital Expenditures -5.809 -0.254 -0.187 -0.341 -0.269
    Other Investing Cash Flow Items, Total -0.367 0 0
    Cash From Financing Activities 113.418 31.921 4.918 19.559 13.416
    Financing Cash Flow Items 0 0 5.435 16.424 0
    Issuance (Retirement) of Stock, Net 18.216 0.132 0.146 0.909 0.92
    Issuance (Retirement) of Debt, Net 95.202 31.789 -0.663 2.226 12.496
    Net Change in Cash 63.464 15.981 -8.536 5.916 1.324
    Foreign Exchange Effects -3.939 0.06 -0.154 0.125
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -7.304 -90.076 -74.069 -62.541 -44.958
    Cash From Operating Activities -8.254 -39.839 -33.442 -28.644 -19.798
    Cash From Operating Activities 0.542 1.476 0.905 0.402 0.281
    Non-Cash Items -0.171 57.174 48.25 44.179 32.52
    Changes in Working Capital -1.321 -8.413 -8.528 -10.684 -7.641
    Cash From Investing Activities -4.075 -6.176 -3.391 -1.237 -0.445
    Capital Expenditures -4.075 -5.809 -3.024 -0.87 -0.445
    Cash From Financing Activities 2.816 113.418 113.478 95.613 91.829
    Financing Cash Flow Items 0 0 0 13.374 45.942
    Issuance (Retirement) of Stock, Net 3.058 18.216 17.765 2.879 2.712
    Issuance (Retirement) of Debt, Net -0.242 95.202 95.713 79.36 43.175
    Foreign Exchange Effects 1.913 -3.939 -1.264 -0.561 1.106
    Net Change in Cash -7.6 63.464 75.381 65.171 72.692
    Other Investing Cash Flow Items, Total 0 -0.367 -0.367 -0.367
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Meretzki (Shai) Individual Investor 32.966 385017966 5551455 2022-12-28
    Rauch (Yosef) Individual Investor 11.383 132945004 875000 2022-12-28
    Shapira (Gil) Individual Investor 0.6085 7106418 0 2022-12-28
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1 1167456 19019 2023-02-28 LOW
    Reznick (Yehuda) Individual Investor 0.0626 730797 0 2022-12-28

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Bio Medical Devices

    פארק מת"מ 8ב'
    HAIFA
    3190501
    IL

    Income Statement

    • Annual
    • Quarterly

    People also watch

    US100

    13,095.30 Price
    +0.990% 1D Chg, %
    Biaya inap posisi Long -0.0249%
    Biaya inap posisi short 0.0027%
    Waktu biaya inap 21:00 (UTC)
    Spread 1.8

    BTC/USD

    28,335.70 Price
    +0.580% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    Oil - Crude

    75.47 Price
    +1.560% 1D Chg, %
    Biaya inap posisi Long -0.0156%
    Biaya inap posisi short -0.0063%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    Gold

    1,969.53 Price
    -0.570% 1D Chg, %
    Biaya inap posisi Long -0.0185%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda